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Abstract: An active site aspartate residue, Asp97, in the methionine
aminopeptidase (MetAPs) from Escherichia coli (EcMetAP-I) was mutated to
alanine, glutamate, and asparagine. Asp97 is the lone carboxylate residue
bound to the crystallographically determined second metal-binding site in
EcMetAP-I. These mutant EcMetAP-I enzymes have been kinetically and
spectroscopically characterized. Inductively coupled plasma–atomic emission
spectroscopy analysis revealed that 1.0 ± 0.1 equivalents of cobalt were
associated with each of the Asp97-mutated EcMetAP-Is. The effect on activity
after altering Asp97 to alanine, glutamate or asparagine is, in general, due to
a ~ 9000-fold decrease in kca towards Met-Gly-Met-Met as compared to the
wild-type enzyme. The Co(II) d–d spectra for wild-type, D97E and D97A
EcMetAP-I exhibited very little difference in form, in each case, between the
monocobalt(II) and dicobalt(II) EcMetAP-I, and only a doubling of intensity
was observed upon addition of a second Co(II) ion. In contrast, the electronic
absorption spectra of [Co_(D97N EcMetAP-I)] and [CoCo(D97N EcMetAP-I)]
were distinct, as were the EPR spectra. On the basis of the observed molar
absorptivities, the Co(II) ions binding to the D97E, D97A and D97N EcMetAP-I
active sites are pentacoordinate. Combination of these data suggests that
mutating the only nonbridging ligand in the second divalent metal-binding site
in MetAPs to an alanine, which effectively removes the ability of the enzyme
to form a dinuclear site, provides a MetAP enzyme that retains catalytic
activity, albeit at extremely low levels. Although mononuclear MetAPs are
active, the physiologically relevant form of the enzyme is probably dinuclear,
given that the majority of the data reported to date are consistent with weak
cooperative binding.
Keywords: EPR, kinetics, mechanism, methionine aminopeptidases, mutants

Methionine aminopeptidases (MetAPs) represent a unique class
of protease that is responsible for the hydrolytic removal of N-terminal
methionines from proteins and polypeptides [1–4]. In the cytosol of
eukaryotes, all proteins are initiated with an N-terminal methionine;
however, all proteins synthesized in prokaryotes, mitochondria and
chloroplasts are initiated with an N-terminal formylmethionyl that is
subsequently removed by a deformylase, leaving a free methionine at
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the N-terminus [2]. The cleavage of this N-terminal methionine by
MetAPs plays a central role in protein synthesis and maturation [5,6].
The physiological importance of MetAP activity is underscored by the
cellular lethality upon deletion of the MetAP genes in Escherichia coli,
Salmonella typhimurium, and Saccharomyces cerevisiae [7–10].
Moreover, a MetAP from eukaryotes has been identified as the
molecular target for the antiangiogenesis drugs ovalicin and fumagillin
[11–15]. Therefore, the inhibition of MetAP activity in malignant
tumors is critical in preventing tumor vascularization, which leads to
the growth and proliferation of carcinoma cells. In comparison to
conventional chemotherapy, antiangiogenic therapy has a number of
advantages, including low cellular toxicity and a lack of drug resistance
[14].
MetAPs are organized into two classes (type I and type II) on
the basis of the absence or presence of an extra 62 amino acid
sequence (of unknown function) inserted near the catalytic domain of
type II enzymes. The type I MetAPs from E. coli (EcMetAP-I),
Staphylococcus aureus, Thermotoga maritima and Homo sapiens and
the type II MetAPs from Homo sapiens and Pyrococcus furiosus
(PfMetAP-II) have been crystallographically characterized [14,16–21].
All six display a novel ‘pita-bread’ fold with an internal pseudo-two-fold
symmetry that structurally relates the first and second halves of the
polypeptide chain to each other. Each half contains an antiparallel βpleated sheet flanked by two helical segments and a C-terminal loop.
Both domains contribute conserved residues as ligands to the divalent
metal ions residing in the active site. Nearly all of the available X-ray
crystallographic data reported to date reveal a bis(µ-carboxylato) (µaquo/hydroxo) dinuclear core with an additional carboxylate residue at
each metal site and a single histidine bound to M1 (Fig. 1) [22,23].
However, extended X-ray absorption fine structure spectroscopy
(EXAFS) studies on Co(II)- and Fe(II)-loaded EcMetAP-I did not reveal
any evidence for a dinuclear site [23]. An X-ray crystal structure of
EcMetAP-I was recently reported with partial occupancy (40%) of a
single Mn(II) ion bound in the active site [24]. This structure was
obtained by adding the transition state analog inhibitor l-norleucine
phosphonate, in order to impede divalent metal binding to the second
site, and by limiting the amount of metal ion present during crystal
growth. This structure provides the first structural verification that
MetAPs can form mononuclear active sites and that the single divalent
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metal ion resides on the His171 side of the active site, as previously
predicted by 1H-NMR spectroscopy and EXAFS [22,23].

Fig. 1: Active site of EcMetAP-I showing the metal-binding residues, including Asp97.
Prepared from Protein Data Bank file 2MAT.

A major controversy currently surrounding MetAPs is whether a
mononuclear site, a dinuclear site or both can catalyze the cleavage of
N-terminal methionines in vivo [22,25,26]. A growing number of
kinetic studies indicate that both type I and type II MetAPs are fully
active in the presence of only one equivalent (eq.) of divalent metal
ion [Mn(II), Fe(II), or Co(II)] [22,25,27]. However, kinetic, magnetic
CD (MCD) and atomic absorption spectrometry data indicated that
Co(II) ions bind to EcMetAP-I in a weakly cooperative fashion (Hill
coefficients of 1.3 or 2.1) [26,28]. These data represent the first
evidence that a dinuclear site can form in EcMetAP-I under
physiological conditions. Moreover, EPR data recorded on Mn(II)loaded EcMetAP-I and PfMetAP-II suggest a small amount of dinuclear
site formation after the addition of only a quarter equivalent of Mn(II)
[22,29,30]. In order to determine whether a dinuclear site is required
for enzymatic activity in MetAPs, the conserved aspartate, which is the
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lone nonbridging ligand for the M2 site in MetAPs (Fig. 2), was
mutated in EcMetAP-I to alanine, glutamate, and asparagine.

Fig. 2: Amino acid sequence alignment for selected MetAPs, prolidase and
aminopeptidase P (AMPP). Prepared from Protein Data Bank files 1C21, 1QXZ, 1O0X,
1XGO, 1BN5, 1PV9, and 1A16.

Results
Metal content of mutant EcMetAP-I enzymes
The number of tightly bound divalent metal ions was determined
for each of the mutant EcMetAP-I enzymes by inductively coupled
plasma–atomic emission spectroscopy (ICP-AES) analysis. Apoenzyme
samples (30 µm), to which 2–30 eq. of Co(II) were added under
anaerobic conditions, were dialyzed for 3 h at 4 °C with Chelex-100treated, metal-free Hepes buffer (25 mm Hepes, 150 mm KCl, pH
7.5). ICP-AES analysis revealed that 1.0 ± 0.1 eq. of cobalt was
associated with each of the Asp97-mutated EcMetAP-I enzymes. As a
control, metal analyses were also performed on the corresponding
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Asp82 mutant PfMetAP-II enzymes. ICP-AES analysis of D82A, D82N
and D82E PfMetAP-II also revealed that 1.0 ± 0.1 eq. of cobalt was
associated with the enzymes.

Kinetic analysis of the mutant EcMetAP-I enzymes
The specific activities of D97A, D97N and D97E EcMetAP-I were
examined using Met-Gly-Met-Met (MGMM) as the substrate. Apo-forms
of the variants were all catalytically inactive. Kinetic parameters were
determined for the Co(II)-reconstituted wild-type and mutated
enzymes (Table 1). In order to obtain detectable activity levels,
reactions of D97A, D97N and D97E EcMetAP-I with MGMM were
allowed to run for > 24 h before quenching of the reactions, as
compared to 1 min for wild-type EcMetAP-I. The extent of the reaction
for the variants was obtained from the time dependence of the activity
of the enzymes. A linear correlation was observed between activity
and time until 30 h, after which the activity values reached a plateau.
As a control, substrate was incubated with apo-EcMetAP-I and in
buffer, neither of which resulted in any observed substrate cleavage.
All three variants exhibited maximum catalytic activity after the
addition of only one equivalent of Co(II), which is identical to what was
found with wild-type EcMetAP-I [22,31].
Table 1: Kinetic parameters for Co(II)-loaded wild-type (WT) and D97
mutated EcMetAP-I towards MGMM at 30 °C and pH 7.5. SA, specific activity.
EcMetAP-I
WT

D97A

D97N

D97E

Km (mm)

3.0 ± 0.1

1.1 ± 0.1

0.6 ± 0.1

1.8 ± 0.1

kcat (s−1)

18.3 ± 0.5

0.003 ± 0.001

0.001 ± 0.0005

0.002 ± 0.001

3.0

2.0

1.0

0.006 ± 0.001

0.002 ± 0.001

0.004 ± 0.001

kcat / Km
SA

(m−1·s−1)

(units·mg−1)

6.0 ×

103

36.1 ± 2

The effect on activity after altering Asp97 to alanine, glutamate
or asparagine is, in general, due to a decrease in kcat. The kcat values
for D97A, D97E and D97N EcMetAP-I are 0.003 ± 0.001, 0.002 ±
0.001, and 0.001 ± 0.0005 s−1, respectively (Table 1). Thus, the kcat
value for the variants towards MGMM decreased ~ 9000-fold as
compared to the wild-type enzyme. For comparison purposes, kcat
values of D82E, D82N and D82A PfMetAP-II were determined, and
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were found to be 10 ± 1, 1.4 ± 0.1, and 0.01 ± 0.005 s−1,
respectively. Thus, the kcat value for D82A PfMetAP-II towards MGMM
decreased ~ 19 000-fold as compared to wild-type PfMetAP-II,
whereas D82E PfMetAP-II was only 19-fold less active. As a control,
we also altered the PfMetAP-II active site histidine (His153), which is
analogous to His171 in EcMetAP-I, to an alanine. This mutation, not
surprisingly, resulted in the complete loss of enzymatic activity.
Moreover, this enzyme does not bind divalent metal ions, as
determined by ICP-AES analysis. These data clearly establish His153
(His171) as an essential active site amino acid involved in metal
binding.
The Km values for each of D97A, D97E and D97N EcMetAP-I
decreased in comparison to that of wild-type EcMetAP-I, with the
largest drop in Km being observed for D97N EcMetAP-I (0.6 ± 0.1
mm), which contains the most conservative substitution. The observed
Km value for D97E EcMetAP-I was 1.8 ± 0.1 mm, whereas D97A
EcMetAP-I exhibited a Km value of 1.1 ± 0.1 mm. Combination of the
observed kcat and Km values for each EcMetAP-I variant provided the
catalytic efficiency (kcat/Km) for the Co(II)-loaded enzymes, which was
decreased 2000-fold, 6100-fold and 3000-fold for D97A, D97E and
D97N EcMetAP-I, respectively, towards MGMM. In order to confirm the
accuracy of the Km values, the dissociation constant (Kd) for MGMM
binding to Co(II)-loaded D97N EcMetAP-I was determined by
isothermal calorimetry (ITC) and found to be 0.9 mm, which is similar
in magnitude to the observed Km value.

Determination of metal-binding constants
ITC measurements were carried out at 25 ± 0.2 °C for D97E,
D97A and D97N EcMetAP-I (Fig. 3). Association constants (Ka) for the
binding of Co(II) were obtained by fitting these data, after subtraction
of the background heat of dilution, via an iterative process using the
origin software package. This software package uses a nonlinear leastsquare algorithm that allows the concentrations of the titrant and the
sample to be fitted to the heat-flow-per-injection to an equilibrium
binding equation for two sets of noninteracting sites. The Ka value, the
metal–enzyme stoichiometry (p) and the change in enthalpy (ΔH°)
were allowed to vary during the fitting process (Table 2, Fig. 3). The
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best fit obtained for D97A EcMetAP-I provided an overall p-value of 2
for two noninteracting sites, whereas the best fit obtained for D97N
EcMetAP-I provided an overall p-value of 3 for three noninteracting
sites. Similarly, the best fit obtained for D97E EcMetAP-I provided an
overall p-value of 3 for three interacting sites. For D97A EcMetAP-I, Kd
values of 1.6 ± 1.2 µm and 2.2 ± 0.4 mm were observed, whereas
D97N EcMetAP-I gave a Kd value of 0.22 ± 0.3 µm and two Kd values
of 0.2 ± 0.1 mm. Interestingly, D97E EcMetAP-I exhibited cooperative
binding, giving Kd values of 90 ± 20, 210 ± 100 and 574 ± 150 µm.
The heat of reaction, measured during the experiment, was converted
into other thermodynamic parameters using the Gibbs free energy
relationship. The thermodynamic parameters obtained from ITC
titrations of Co(II) with wild-type EcMetAP-I and each mutant enzyme
reveal changes that affect both of the metal-binding sites (Table 3).
Although the predominant effect is on the second metal-binding site,
substitution of Asp97 by glutamate and asparagine makes the process
of binding of the metal ions, particularly for the second metal ion,
more spontaneous on the basis of more negative Gibbs free energy
(ΔG) values in comparison to the wild-type enzyme. Substitution of
Asp97 by alanine does not affect the ΔG value for the binding of the
first metal ion; however, the entropic factor (TΔS) for the binding of
the first metal ion decreases in the relative order D97E > wild type >
D97N > D97A. In addition, TΔS for binding of the second metal ion
significantly decreases for D97N EcMetAP-I but remains similar in
magnitude for D97E EcMetAP-I in comparison to the wild-type enzyme.
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Fig. 3: ITC titration of 70 µm solution of D97E EcMetAP-I with a 5 mm Co(II) solution
at 25 °C in 25 mm Hepes (pH 7.5) and 150 mm KCl.
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EcMetAP-I

p

WT

1

1.6 ± 0.5

2

14 000 ± 5000

D97A
D97N
D97E

Kd1, Kd2 (µm)

1

1.6 ± 1.2

1

2237 ± 476

1

0.22 ± 0.3

2

238 ± 100

1

90 ± 20

1

210 ± 100

1
574 ± 150
Table 2: Dissociation constants (Kd) and metal–enzyme stoichiometry (n) for Co(II)
binding to wild-type (WT) and variant EcMetAP-I. For each set of data for both WT and
variant EcMetAP-I, p is the number of Co(II) ions per protein. Data for p = 1 are for
one Co(II) ion that bound tightly, and data for p = 2 represent two Co(II) ions binding
to sites on the protein with lower affinity. WT data have been reported in [49].

EcMetAP-I

ΔH1, ΔH2
p (kcal / mol)

TΔS1,TΔS2
(kcal·mol−1)

ΔG1, ΔG2
(kcal·mol−1)

WT

1 1.54 × 101

2.33 × 101

−7.91

103

103

−2.51

1 1.42 × 100

9.35 × 100

−7.90

101

101

−3.61

1 1.40 × 100

1.05 × 101

−9.07

100

100

−4.94

8.12 × 103

−5.49

2 1.06 ×
D97A

1 1.64 ×
D97N

2 4.20 ×
D97E

1 6.31 × 10−1
1 5.03 ×

100

1.06 ×
2.00 ×
9.14 ×

10.02 ×

103

−4.99

1 6.20 × 100
10.60 × 103
−4.40
Table 3: Thermodynamic parameters for Co(II) binding to wild-type (WT) and variant
EcMetAP-I.

Electronic absorption spectra of Co(II)-loaded mutated
EcMetAP-I
The electronic absorption spectra of wild-type, D97A, D97N and
D97E EcMetAP-I with the addition of one and two equivalents of Co(II)
were recorded under strict anaerobic conditions in 25 mm Hepes buffer
(pH 7.5) and 150 mm KCl (Fig. 4). The addition of one equivalent of
Co(II) to wild-type, D97A, D97N and D97E EcMetAP-I provided
electronic absorption spectra with three absorption maxima between
540 and 700 nm, with molar absorptivities ranging from 20 to 80
m−1·cm−1. In general, the addition of a second equivalent of Co(II)
increased the molar absortivities of the absorption bands. However, for
D97N EcMetAP-I, molar absorptivity increased for maxima at 550 and
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630 nm but diminished for the maxima at 690 nm (Fig. 4). Addition of
further equivalents of Co(II) led to precipitation for D97N EcMetAP-I,
no change in molar absorptivity of the absorption maxima for D97A
EcMetAP-I, but an increase in molar absorptivity for D97E EcMetAP-I.

Fig. 4: Electronic absorption spectra of 1 mm wild-type (black), D97A (green), D97N
(blue) and D97E (red) EcMetAP-I with increments of one and two equivalents of Co(II)
in 25 mm Hepes buffer (pH 7.5) and 150 mm KCl.

For D97E EcMetAP-I, the dissociation constant for the second
metal-binding site was determined by subtraction of the UV–visible
spectrum with one equivalent of Co(II) from the other spectra and
then plotting a binding curve (Fig. 5). The dissociation constants (Kd)
for the second divalent metal-binding sites of EcMetAP-I D97E were
obtained by fitting the observed molar absorptivities to Eqn (1), via an
iterative process that allows both Kd and p to vary (Fig. 5):

r=pCS/(Kd+CS)
(1)
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where p is the number of sites for which interaction with M(II) is
governed by the intrinsic dissociation constant Kd, and r is the binding
function calculated by conversion of the fractional saturation (fa) [32]:

r=𝑓ap
(2)
CS, the free metal concentration, was calculated from

CS=CTS−rCA
(3)
where CTS and CA are the total molar concentrations of metal and
enzyme, respectively. The best fit obtained for the λmax values at 520,
627 and 685 nm provided a P-value of 1 and Kd values of 0.3 ± 0.1,
1.1 ± 0.2 and 0.6 ± 0.6 mm, respectively, for D97E EcMetAP-I (Table
4).

Fig. 5: Binding function r versus CS, the concentration of free metal ions in solution for
D97E EcMetAP-I in 25 mm Hepes buffer (pH 7.5) and 150 mm KCl at three different
wavelengths. The solid lines correspond to fits of each data set to Eqn (3).
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λmax (nm) Kd (mm)
520
0.3 ± 0.1
627
1.1 ± 0.2
685

0.6 ± 0.6

Table 4: Data obtained for the fits of electronic absorption data to Eqn (1).

EPR studies of Co(II)-loaded D97A, D97E and D97N
EcMetAP-I
The EPR spectrum of wild-type EcMetAP-I (Fig. 6A) has been
well characterized [22], and the form of the signal is invariant from
0.5 to 2.0 eq. of Co(II). The signal is due to transitions in the MS = | ±
1/2〉 Kramers’ doublet of S = 3/2, with Δ > gβBS, and exhibits no
resolved rhombicity or 59Co hyperfine structure. This type of signal is
typical for protein-bound five- or six-coordinate Co(II) with one or
more water ligands. A very similar signal was obtained with the monoCo(II) form of D97A EcMetAP-I (Fig. 6K) and with the di-Co(II) forms
of both D97A (Fig. 6L) and D97N (Fig. 6H,J) EcMetAP-I.
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Fig. 6
Co(II)-EPR of EcMetAP-I and variants. Traces A, B and D are the EPR spectra of
[CoCo(WT-EcMetAP-I)] (A), [Co_(D97E-EcMetAP-I)] (B), and [CoCo(D97E-EcMetAP-I)]
(D). Trace C is a computer simulation of B assuming two species. The major species
exhibited resolved hyperfine coupling and was simulated with spin Hamiltonian
parameters S = 3/ 2, MS = |± 1/ 2〉, gx,y = 2.57, gz = 2.67, D >> g BS (50 cm-1), E /
D = 0.185, Ay = 9.0 × 10−3 cm−1. The minor species was best simulated (gx,y = 2.18,
gz = 2.6, E / D = 1/ 3, Ay (unresolved) = 4.5 × 10−3 cm−1) assuming some unresolved
hyperfine coupling, although no direct evidence for this was obtained. Trace E is of
spectrum D with arbitrary amounts of spectrum A subtracted. Trace F is the
experimental EPR spectrum of [CoCo(D97E- EcMetAP-I)] recorded in parallel mode
(B0║ B1). Traces G and I are spectra of [Co_(D97N- EcMetAP-I)], and traces H and J
are spectra of [CoCo(D97N- EcMetAP-I)]; the insert of H shows the hyperfine region of
G expanded. Trace K is the spectrum of [Co_(D97A- EcMetAP-I)], and L is of
[CoCo(D97A-EcMetAP-I)]. Spectra A, B, D and I–K were recorded using 0.2 mW power
at 8 K. Spectrum F was recorded using 20 mW at 8 K, and spectra G and H were
recorded using 2 mW at 6 K. Trace G is shown × 2 compared to H, I is shown × 2
compared to J, and K is shown × 2 compared to L. Other intensities are arbitrary.
Spectrum F was recorded at 9.37 GHz whereas all other experimental spectra were at
9.64 GHz.
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The EPR signals from D97E EcMetAP-I were, however,
significantly different from those of wild-type EcMetAP-I. The signal
observed for [Co_(D97E EcMetAP-I)] (Fig. 6B) was complex, and
computer simulation (Fig. 6C) suggested a dominant species that
exhibited marked rhombic distortion of the axial zero-field splitting
(E/D = 0.185) and a 59Co hyperfine interaction of 9 × 10−3 cm−1.
These parameters are typical for low-symmetry five-coordinate Co(II)
with a constrained ligand sphere, and suggest that either Co(II) is
displaced relative to that in [Co_(wild-type EcMetAP-I)] and binds in a
very different manner altogether, or that the binding mode of the
carboxylate differs, perhaps being bidentate in D97E EcMetAP-I and
replacing a water ligand. Further differences between the binding
modes of Co(II) were observed in the dicobalt(II) form of D97E
EcMetAP-I. Whereas there was no evidence for significant exchange
coupling in spectra obtained for wild-type EcMetAP-I, the spectrum of
[CoCo(D97E EcMetAP-I)] (Fig. 6D) exhibited a feature at geff ~ 12 that
was suggestive of an integer spin system with S′ = 3. Subtraction of
the [Co_(D97E EcMetAP-I)] spectrum and the wild-type spectrum
yielded a difference spectrum (Fig. 6E) with similarities to integer spin
signals observed in other dicobalt(II) systems [33], and the parallel
mode EPR signal, with a resonance at geff ~ 11 (Fig. 6F), confirmed
that the Co(II) ions in [CoCo(D97E EcMetAP-I)] do indeed form a
weakly exchange-coupled dinuclear center.
Close examination of the EPR signal from [Co_(D97N EcMetAPI)] recorded at 6 K (Fig. 6G) revealed a 59Co hyperfine pattern
superimposed on the dominant axial signal, indicating the presence of
two species of Co(II). The pattern was centered at geff ~ 7.9 and,
interestingly, no other features that could be readily associated with
this pattern were evident. It is possible, then, that the hyperfine
pattern in the spectrum of [Co_(D97N EcMetAP-I)] is part of an MS = |
± 3/2〉 signal, indicative of tetrahedral character for Co(II) ions, for
which the g⊥ features are unobservable at 9.6 GHz. This explanation is
also consistent with the loss of the hyperfine pattern upon an increase
of the temperature by a mere 2 K; MS = | ±3/2〉 signals are often only
observed at temperatures around 5 K, because of rapid relaxation at
higher temperatures [34–36]. Despite the superficial similarity of the
hyperfine patterns observed in the spectra of [Co_(D97N EcMetAP-I)]
and [Co_(D97E EcMetAP-I)], the Co(II) species from which these
originate are probably very different. An additional difference between
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D97N and D97E EcMetAP-I is the lack of evidence for exchange
coupling in [CoCo(D97N EcMetAP-I)]; the formation of a spin-coupled
dinuclear center appears to be unique to D97E EcMetAP-I.

Discussion
A major stumbling block in the design of small molecule
inhibitors of MetAPs centers on how many metal ions are present in
the active site under physiological conditions. Most of the X-ray
crystallographic data reported for MetAPs indicate that two metal ions
form a dinuclear active site [24,37–42]. However, kinetic data suggest
that only one metal ion is required for full enzymatic activity, and
EXAFS studies on Co(II)-and Fe(II)-loaded EcMetAP-I did not provide
any evidence for a dinuclear site [22,23,25,27]. Recently, the X-ray
crystal structure of a mono-Mn(II) EcMetAP-I enzyme bound by lnorleucine phosphonate was reported, providing the first
crystallographic data for a mononuclear MetAP [24]. Taken together,
these data suggest that MetAPs are mononuclear exopeptidases,
however, kinetic, MCD and atomic absorption spectrometry data
indicate that Co(II) ions bind to EcMetAP-I in a weakly cooperative
fashion [26,28]. In order to reconcile these data and determine
whether a dinuclear site is required for enzymatic activity, as well as
shed some light on the catalytic role of Asp97 in EcMetAP-I, we
prepared the D97A, D97E and D97N mutant enzymes. This aspartate
is strictly conserved in all MetAPs as well as in other enzymes in the
‘pita-bread’ superfamily (e.g. aminopeptidase P and prolidase) (Fig. 2)
[14,16,17,19,21,43–46]. Replacement of this conserved aspartate in
human prolidase by asparagine causes skin abnormalities, recurrent
infections, and mental retardation [45].
On the basis of ICP-AES analyses, both D97A EcMetAP-I and
D82A PfMetAP-II bind only one divalent metal ion tightly, which is
identical to what is seen with the wild-type enzyme [22,25]. Therefore,
the second metal ion is either not present or is loosely associated.
Consistent with ICP-AES analyses, the Kd value determined for D97A
EcMetAP-I using ITC indicates the presence of only one tightly bound
divalent metal ion, and the Kd1 is not affected as compared to the wildtype enzyme [22,25]. Therefore, the Kd1 value observed for D97A
EcMetAP-I appears to correspond to the microscopic binding constant
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of a single metal ion to the histidine-containing side of the EcMetAP-I
active site, consistent with the hypothesis that substitution of Asp97, a
residue that functions as the only nonbridging ligand for the second
metal-binding site, effectively eliminates the ability of a second
divalent metal ion to bind in the active site. For wild-type EcMetAP-I,
two additional weak metal-binding events are also observed. Rather
than three total observed metal-binding sites, D97A EcMetAP-I binds
only two Co(II) ions, the second probably being in a remote Co(II)binding site identified in the X-ray crystal structure of EcMetAP-I
[15,19]. This remote metal-binding site, or third metal-binding site,
was also observed in the structure of the type I methionine
aminopeptidase from H. sapiens [21]. In both enzymes, this remote
site is on the outer edge of the enzyme and becomes at least partially
occupied at Co(II) concentrations near 1 mm. Therefore, the second
divalent metal-binding event observed via ITC for D97A EcMetAP-I is
postulated to be due to the binding of a Co(II) ion to the remote
divalent metal-binding site with a Kd2 of 2.2 mm.
ICP-AES data obtained with D97N and D97E EcMetAP-I are also
consistent with ITC data, in that only one tightly bound divalent metal
ion is present in these enzymes. Interestingly, the ITC data obtained
for D97E EcMetAP-I can only be fitted on the assumption of positive
cooperativity, similar to that reported by Larrabee et al. for wild-type
EcMetAP-I [26]. The enhanced cooperativity observed for D97E versus
wild-type EcMetAP-I is probably due to the increased carbon chain
length of glutamate versus aspartate, which may adjust the position of
the second metal-binding site. Similar to what is seen with wild-type
EcMetAP-I, two weak binding events are also observed for D97N and
D97E EcMetAP-I, suggesting that a second metal ion can still bind to
the dinuclear active site even when the bidentate ligand aspartate is
replaced by glutamate or asparagine. However, the ability of D97N and
D97E EcMetAP-I to bind a second divalent metal ion increases ~ 60fold as compared to wild-type EcMetAP-I.
The observed kcat values for D97A EcMetAP-I in the presence of
three equivalents of Co(II) at pH 7.5 decreased 6100-fold as compared
to the wild-type enzyme. D97N and D97E EcMetAP-I are also slightly
active, but neither of these mutant enzymes recover wild-type activity
levels. These data are consistent with a previous study on D97A
EcMetAP-I, where it was reported that ~ 4% of the residual activity of
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wild-type EcMetAP-I was retained [47]. On the basis of these data, this
strictly conserved aspartate is a catalytically important residue but is
not absolutely required for enzymatic activity. The fact that catalytic
activity is observed for both D97A EcMetAP-I and D82A PfMetAP-II,
enzymes in which the second divalent metal-binding site has probably
been eliminated, suggests that MetAP enzymes can function as
mononuclear enzymes. Interestingly, the observed Km value for D97A
EcMetAP-I, which is a partial indicator of the affinity of an enzyme for
its substrate, decreased by ~ 2.7-fold, suggesting that D97A EcMetAPI binds MGMM more tightly than the wild-type enzyme. The
combination of these data provides a catalytic efficiency for D97A
EcMetAP-I that is ~ 4000-fold poorer than that of wild-type EcMetAP-I.
This result is significant in light of the evidence that metal binding to
D97A EcMetAP-I is probably not cooperative and dinuclear sites do not
appear to form.
Further insight into the structure–function relationships of the
metal-binding sites of EcMetAP-I comes from electronic absorption and
EPR spectroscopy. The Co(II) d–d spectra for wild-type, D97E and
D97A EcMetAP-I exhibited very little difference in form, in each case,
between the monocobalt(II) and dicobalt(II) forms, and only a
doubling of intensity was observed upon addition of a second Co(II)
ion. For wild-type and D97A EcMetAP-I, this was reflected in the EPR
spectra, which also did not differ significantly between the
monocobalt(II) and dicobalt(II) forms. In contrast, the electronic
absorption spectra of [Co_(D97N EcMetAP-I)] and [CoCo(D97N
EcMetAP-I)] are distinct, as are the EPR spectra. On the basis of the
observed molar absorptivities, the Co(II) ions binding to the D97E,
D97A and D97N EcMetAP-I active sites are pentacoordinate [48] and,
apart from a putative tetrahedral species implied by a minor
component of the EPR spectrum of [Co_(D97N EcMetAP-I)], the EPR
spectra are all consistent with this interpretation, with high axial
symmetry being seen in D97A and D97N EcMetAP-I. The minor
component in D97N EcMetAP-I that is tentatively assigned as a
tetrahedral Co(II) may be in equilibrium (in solution) with the
dominant five-coordinate form, and the EPR signal due to this species
was not exhibited by the dicobalt(II) form of D97N EcMetAP-I. This, in
turn, suggests that rearrangement of the active site upon binding a
second Co(II) ion leads to a preference for the higher coordination
geometry, perhaps due to stabilization of a hitherto weakly bound
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water ligand by either bridging the two Co(II) ions or via hydrogen
bonding.
EPR spectra obtained for D97E EcMetAP-I are particularly
interesting, and indicate: (a) a much more distorted five-coordinate
geometry for the first Co(II) ion with a much more rigid ligand
complement, which probably lacks a solvent ligand; and (b) the
formation of a weakly exchange-coupled bona fide dinuclear site upon
the addition of two Co(II) ions. Taken together, the EPR data obtained
for D97E EcMetAP-I suggest that the loss of aspartate at position 97 is
not responsible for the observed change in the Co(II) environment of
the M1 site, but rather the presence of the glutamate side chain. It is
tempting to speculate that Glu97 provides one or more ligands to the
first Co(II)-binding site, and indeed bidentate binding of Glu97 may
prevent binding of the solvent ligand that appears to be present in
other mono-cobalt(II) species of EcMetAP-I.
Combination of these data suggests that mutating the only
nonbridging ligand in the second divalent metal-binding site in MetAPs
to an alanine, which effectively removes the ability of the enzyme to
form a dinuclear site, provides a MetAP enzyme that retains catalytic
activity, albeit at extremely low levels. Reconciliation of these data
with kinetic, ITC, crystallographic and EXAFS data suggesting that
MetAPs are mononuclear with kinetic, MCD and EPR data indicating
that metal binding is cooperative, at first glance, appears to be tricky
[22,24,26,29,30]. However, the most logical explanation leads to the
conclusion that metal binding to MetAPs is cooperative, and that
discrepancies have arisen due to the concentrations of the enzyme
samples used in the various experiments. For example, ITC data do
not reveal cooperative binding for divalent metal ions to EcMetAP-I or
PfMetAP-II but, instead, indicate that one metal ion binds with much
higher affinity than subsequent metal ions. It should be noted that ITC
titrations are typically run with enzyme concentrations of 70 µm, and
most often reveal two sets of binding sites, similar to that observed for
D97N EcMetAP-I [22]. Likewise, initial activity assays carried out on
EcMetAP-I and PfMetAP-II used an enzyme concentration of 20 µm,
which is two orders of magnitude larger than the Kd value determined
for the first metal-binding site of 0.2 or 0.4 µm, assuming Hill
coefficients of 1.3 or 2.1, respectively [26,28]. However, a Kd value of
between 2.5 and 4.0 µm was reported if it was assumed that only a
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single Co(II)-binding site exists in the low-concentration regime, which
is within the error of ITC and kinetic Kd values. Spectroscopic and most
X-ray crystallographic measurements were carried out at much higher
enzyme (~ 1 mm) and metal concentrations, where a significant
concentration of dinuclear sites will undoubtedly be present. Under the
conditions utilized in ITC experiments, any cooperativity in divalent
metal binding will not be detectable, but may appear in EPR and
electronic absorption data. As activity titrations and ITC data are not
particularly sensitive to the type of binding (i.e. cooperativity versus
two independent binding sites), the weak cooperativity observed by
Larrabee et al. [26] will not be observed in these experiments but is
entirely consistent with the EPR and electronic absorption data and,
indeed, with recent X-ray crystallographic data. Most X-ray structures
of MetAPs were determined with a large excess of divalent metal ions,
so only dinuclear sites were observed. However, crystallographic data
obtained on EcMetAP-I using metal ion / enzyme ratios of 0.5 : 1
reveal metal ion occupancies of 71% bound to the M1 site and 28%
bound to the M2 site, consistent with cooperative binding [24].
In conclusion, mutating the only nonbridging ligand in the
second divalent metal-binding site in MetAPs to an alanine, which
effectively removes the ability of the enzyme to form a dinuclear site,
provides MetAPs that retain catalytic activity, albeit at extremely low
levels. Although mononuclear MetAPs are active, the physiologically
relevant form of the enzyme is probably dinuclear, given that the
majority of the data reported to date are consistent with weak
cooperative binding. Therefore, Asp97 primarily functions as a ligand
for the second divalent metal-binding site, but also probably assists in
binding and positioning the substrate through interactions with the Nterminal amine. The data reported herein highlight the complexity of
the active site of EcMetAP-I, and provide additional insights into the
role that active site residues play in the hydrolysis of peptides by
MetAPs as well as aminopeptidase P and prolidase.
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Experimental procedures
Mutagenesis, protein expression and purification
Altered forms of EcMetAP-I were obtained by PCR mutagenesis
using the following primers: 5′-GGC GAT ATC GTT AAC ATT XXX GTC
ACC GTA ATC AAA GAT GG-3′ and 5′-CCA TCT TTG ATT ACG GTG AC
YYY A ATG TTA ACG ATA TCG CC-3′, with XXX standing for GCT, AAT,
or GAG, and YYY standing for AGC, TTA, or CTC, of EcMetAP-I D97A,
D97N and D97E. Site-directed mutants were obtained using the Quick
Change Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA),
following Stratagene’s procedure. Reaction products were transformed
into E. coli XL1-Blue competent cells (recA1 endA1 gyrA96 thi-1
hsdR17 supE44 relA1 lac [F′ proAB lacIqZΔ M15 Tn10(Tetr)]), grown
on LB agar plates containing kanamycin at a concentration of 50
µg·mL−1. A single colony of each mutant was grown in 50 mL of LB
containing 50 µg·mL−1 kanamycin. Plasmids were isolated using Wizard
Plus Miniprep DNA purification kits (Promega, Madison, WI, USA) or
Qiaprep Spin Miniprep kits (Qiagene, Valencia, CA, USA). Each
mutation was confirmed by DNA sequencing (USU Biotechnology
Center). Plasmids containing the altered EcMetAP-I genes were
transformed into E. coli BL21 Star(DE3) [F− ompT hsdSB (rB −mB −) gal
dcm rne131 (DE3)] (Invitrogen, Carlsbad, CA, USA), and stock
cultures were prepared. The variants were purified in an identical
manner to the wild-type enzyme [15,31]. Purified variants exhibited a
single band on SDS /PAGE at an Mr of 29 630. Protein concentrations
were estimated from the absorbance at 280 nm using an extinction
coefficient of 16 445 m−1·cm−1 [12,18]. Apo-EcMetAP-I was washed
free of methionine using Chelex-100-treated methionine-free buffer
(25 mm Hepes, pH 7.5, 150 mm KCl) and concentrated by microfiltration using a Centricon-10 (Amicon, Beverly, MA, USA) prior to all
kinetic assays. Individual aliquots of apo-EcMetAP-I were routinely
stored at −80 °C or in liquid nitrogen until needed. Similarly, we also
prepared D82E, D82N and D82A PfMetAP-II and purified them to
homogeneity, according to SDS /PAGE analysis.
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Metal content measurements
Mutated EcMetAP-I enzyme samples prepared for metal analysis
were typically 30 µm. Apo-EcMetAP-I samples were incubated
anaerobically with MCl2, where M = Co(II), for 30 min prior to
exhaustive anaerobic exchange into Chelex-100-treated buffer as
previously reported [31]. Metal analyses were performed using ICPAES.

Enzymatic assay of EcMetAP-I enzymes
All enzymatic assays were performed under strict anaerobic
conditions in an inert atmosphere glove box (Coy) with a dry bath
incubator to maintain the temperature at 30 °C. Catalytic activities
were determined with an error of ± 5%. Enzyme activities for each
mutated enzyme were determined in 25 mm Hepes buffer (pH 7.5)
containing 150 mm KCl with the tetrapeptide substrate MGMM. The
amount of product formation was determined by HPLC (Shimadzu LC10A class-VP5). A typical assay involved the addition of 8 µL of metalloaded EcMetAP-I enzyme to a 32 µL substrate–buffer mixture at
30 °C for 1 min. The reaction was quenched by the addition of 40 µL of
a 1% trifluoroacetic acid solution. Elution of the product was monitored
at 215 nm following separation on a C8 HPLC column (Phenomenex,
Luna; 5 µm, 4.6 × 25 cm), as previously described [22,31]. Enzyme
activities are expressed as units per milligram, where one unit is
defined as the amount of enzyme that releases 1 µmol of product in 1
min at 30 °C.

ITC
ITC measurements were carried out on a MicroCal OMEGA
ultrasensitive titration calorimeter. The titrant (CoCl2) and apoEcMetAP-I solutions of the mutated enzymes were prepared in Chelex100-treated 25 mm Hepes buffer at pH 7.5, containing 150 mm KCl.
Stock buffer solutions were thoroughly degassed before each titration.
The enzyme solution (70 µm) was placed in the calorimeter cell and
stirred at 200 r.p.m. to ensure rapid mixing. Typically, 3 µL of titrant
was delivered over 7.6 s with a 5-min interval between injections to
allow for complete equilibration. Each titration was continued until
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4.5–6 eq. of Co(II) had been added, to ensure that no additional
complexes were formed in excess titrant. A background titration,
consisting of the identical titrant solution but only the buffer solution in
the sample cell, was subtracted from each experimental titration to
account for heat of dilution. These data were analyzed with a two- or
three-site binding model by the Windows-based origin software
package supplied by MicroCal [49].

Spectroscopic measurements
Electronic absorption spectra were recorded on a Shimadzu UV3101PC spectrophotometer. All variant apo-EcMetAP-I samples used in
spectroscopic measurements were made rigorously anaerobic prior to
incubation with Co(II) (CoCl2, ≥ 99.999%; Strem Chemicals,
Newburyport, MA) for ~ 30 min at 25 °C. Co(II)-containing samples
were handled throughout in an anaerobic glove box (Ar /5% H2, ≤ 1
p.p.m. O2; Coy Laboratories) until frozen. Electronic absorption spectra
were normalized for the protein concentration and the absorption due
to uncomplexed Co(II) (ε512 nm = 6.0 m−1·cm−1) [22]. Low-temperature
EPR spectroscopy was performed using either a Bruker ESP-300E or a
Bruker EleXsys spectrometer equipped with an ER 4116 DM dual mode
X-band cavity and an Oxford Instruments ESR-900 helium flow
cryostat. Background spectra recorded on a buffer sample were
aligned with and subtracted from experimental spectra as in earlier
work [33,50]. EPR spectra were recorded at microwave frequencies of
approximately 9.65 GHz: precise microwave frequencies were
recorded for individual spectra to ensure precise g-alignment. All
spectra were recorded at 100 kHz modulation frequency. Other EPR
running parameters are specified in the figure legends for individual
samples. EPR simulations were carried out using matrix diagonalization
(xsophe, Bruker Biospin), assuming a spin Hamiltonian H = βgHS +
SDS + SAI, with S = 3/ 2 and D > βgHS (= hν). Enzyme
concentrations for EPR were 1 mm. Mutated enzyme samples for EPR
were frozen after incubation with the appropriate amount of Co(II) for
60 min at 25 °C.
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Abbreviations
EcMetAP-I type I methionine aminopeptidase from Escherichia coli
eq.

equivalent

EXAFS

extended X-ray absorption fine structure spectroscopy

ICP-AES

inductively coupled plasma–atomic emission spectroscopy

ITC

isothermal calorimetry

MCD

magnetic CD

MGMM

Met-Gly-Met-Met

PfMetAP-II type II methionine aminopeptidase from Pyrococcus furiosus
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